Free Float 73,30 %
Shares Float 647,39 M
Shares Outstanding 883,24 M
Hybio Pharmaceutical Co., Ltd.
Share · CNE1000011T7 (XSHE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Hybio Pharmaceutical Co., Ltd.
No Price
Closing Price XSHE 29.04.2026:
20,98 CNY
29.04.2026 07:04
Current Prices from Hybio Pharmaceutical Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SHENZHEN STOCK EXCHANGE |
300199.SZ
|
CNY
|
29.04.2026 07:04
|
20,98 CNY
| -1,12 CNY
-5,07 %
|
Share Float & Liquidity
Company Profile for Hybio Pharmaceutical Co., Ltd. Share
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory and dossier support, etc. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.
Company Data
Name Hybio Pharmaceutical Co., Ltd.
Company Hybio Pharmaceutical Co., Ltd.
Website
https://www.hybio.com.cn
Primary Exchange
SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
ISIN CNE1000011T7
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Shaogui Zeng
Market Capitalization 20 Mrd.
Country China
Currency CNY
Employees 0,9 T
Address Hanyu Biological Park, No. 37, 518057 Shenzhen
IPO Date 2011-04-07
Dividends from 'Hybio Pharmaceutical Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 19.04.2018 | 0,20 CNY |
| 22.06.2017 | 0,10 CNY |
| 02.06.2016 | 0,03 CNY |
| 14.04.2015 | 0,10 CNY |
| 26.04.2013 | 0,20 CNY |
| 17.05.2012 | 0,50 CNY |
Stock Splits
| Date | Split |
|---|---|
| 14.04.2015 | 2:1 |
| 26.04.2013 | 2:1 |
| 17.05.2012 | 2:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| SHENZHEN STOCK EXCHANGE | 300199.SZ |
More Shares
Investors who hold Hybio Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
